These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34731453)

  • 41. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.
    Kito F; Oyama R; Noguchi R; Hattori E; Sakumoto M; Endo M; Kobayashi E; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jan; 33(1):283-290. PubMed ID: 31625124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
    Han YX; Liang DY
    Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
    Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
    Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma.
    Osaki J; Noguchi R; Ono T; Adachi Y; Iwata S; Toda Y; Funada T; Iwata S; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 Nov; 37(6):1734-1741. PubMed ID: 39174825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
    Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.
    Ogura K; Hosoda F; Nakamura H; Hama N; Totoki Y; Yoshida A; Ohashi S; Rokutan H; Takai E; Yachida S; Kawai A; Tanaka S; Shibata T
    Genes Chromosomes Cancer; 2017 Oct; 56(10):711-718. PubMed ID: 28545165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
    Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Ono T; Akiyama T; Hirabayashi K; Ozawa I; Nakagawa R; Kikuta K; Kondo T
    Hum Cell; 2022 Jul; 35(4):1279-1289. PubMed ID: 35637403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.
    Fellenberg J; Sähr H; Kunz P; Zhao Z; Liu L; Tichy D; Herr I
    Cancer Lett; 2016 Feb; 371(1):134-41. PubMed ID: 26655997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
    Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Ono T; Toki S; Kobayashi E; Arakawa A; Sugiyama M; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Adachi Y; Ono T; Tsuchiya R; Sato C; Iwata S; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2023 Jan; 36(1):468-475. PubMed ID: 36436139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
    Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Iwata S; Sugaya J; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors.
    Oyama R; Kito F; Takahashi M; Hattori E; Noguchi R; Takai Y; Sakumoto M; Qiao Z; Toki S; Sugawara M; Tanzawa Y; Kobayashi E; Nakatani F; Iwata S; Yoshida A; Kawai A; Kondo T
    Cancer Cell Int; 2020; 20():58. PubMed ID: 32099531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
    Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
    Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
    Noh BJ; Park YK
    Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
    Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
    PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.